Skip to content

EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia

Usefulness of Unipolar and Bipolar Electrograms in Predicting Successful Ablation Site During Idiopathic Outflow Tract Ventricular Arrhythmia Ablation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02722577
Enrollment
20
Registered
2016-03-30
Start date
2016-03-31
Completion date
2017-05-31
Last updated
2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Outflow Tract Tachycardia

Brief summary

Investigate the value of unipolar and bipolar electrograms (EGM) for predicting the successful ablation site for idiopathic outflow tract ventricular arrhythmia (OTVA).

Detailed description

The proposed study aims to evaluate the predictive value of using reversed polarity in adjacent bipolar EGMs (bi-RP method) and unipolar EGM with QS morphology (uni-QS method) for identifying successful ablation site, and evaluate the feasibility of enhancing uni-QS method's performance by using its morphology characteristics such as descending slope and symmetry.

Interventions

A procedure that uses radiofrequency energy to destroy a small area of heart tissue that is causing rapid and irregular heartbeats.

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo ablation for idiopathic OTVA * Have the ability to provide informed consent for study participation.

Exclusion criteria

* Be currently participating in any other investigational study * Be less than 18 years of age * Be pregnant * Has any other conditions that are not suitable for catheter ablation (including but are not limited to active whole-body infection or sepsis, coagulation or hemorrhage disorder history)

Design outcomes

Primary

MeasureTime frame
Percent of Ablation Targets With Termination of the Clinical Ventricular Arrhythmia After RF Energy DeliveryIntraoperative, an average of 2 hours

Participant flow

Pre-assignment details

Presence of clinical arrhythmia during the ablation procedure is a requirement for the study protocol and can not be guaranteed at the time of enrollment. 2 of the patients who have consented did not have clinical arrhythmia present at the time of the ablation procedure and were therefore not included in the study.

Participants by arm

ArmCount
Main Group
All patients enrolled in this study
20
Total20

Baseline characteristics

CharacteristicMain Group
Age, Continuous48 years
STANDARD_DEVIATION 16
Diabetes mellitus (%)0 Participants
Height (cm)165 cm
STANDARD_DEVIATION 8
Hypertension (%)2 Participants
Origin of arrhythmia in left ventricle outflow tract4 Participants
QRS duration (ms)147 ms
STANDARD_DEVIATION 16
Race and Ethnicity Not Collected— Participants
Region of Enrollment
China
20 Participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
7 Participants
Weight (kg)69 kg
STANDARD_DEVIATION 9

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Percent of Ablation Targets With Termination of the Clinical Ventricular Arrhythmia After RF Energy Delivery

Time frame: Intraoperative, an average of 2 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Main GroupPercent of Ablation Targets With Termination of the Clinical Ventricular Arrhythmia After RF Energy Delivery20 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026